Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: Biologic and therapeutic implications

Hepatology

Volumn 34, Issue 3, 2001, Pages 502-510

  Kirimlioglu, Hale ^a   Dvorchick, Igor ^a   Ruppert, Kris ^a   Finkelstein, Sydney ^a   Marsh, J Wallis ^a   Iwatsuki, Shunzaburo ^a   Bonham, Andrew ^a   Carr, Brian ^a   Nalesnik, Michael ^a   Michalopoulos, George ^a   Starzl, Thomas ^a   Fung, John ^a   Demetris, Anthony ^a  

^a GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MITOSIS; PREDICTION; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0034878014     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.26633     Document Type: Article

References (47)

1. Multistage carcinogenesis
2. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): A follow-up study
3. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma
4. Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: A comparative study
5. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors
6. Hepatocyte proliferation in stepwise development of experimental liver cell cancer
7. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model
8. Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis
9. Low proliferative activity in macroregenerative nodules: Evidence for an alternate hypothesis concerning human hepatocarcinogenesis
10. Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodules
11. Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma
12. Liver transplantation in the treatment of hepatocellular carcinoma
13. Liver transplantation for hepatocellular carcinoma: A proposal of a prognostic scoring system
14. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?
15. Pathology of liver transplantation
16. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinorra after orthotopic liver transplantation: A pilot study
17. Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes
18. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas
19. A molecular genetic model of human bladder cancer pathogenesis
20. Genetic and molecular markers of urothelial premalignancy and malignancy
21. Pathology of carcinoma in situ of the urinary bladder and related lesions
22. Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions
23. Hepatocellular carcinoma
24. Atypical adenomatous hyperplasia' in liver cirrhosis: Low-grade hepatocellular carcinoma or borderline lesion?
25. Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: The M113-1 labeling index is the most effective parameter
26. Expression of proliferation associated antigens and detection of numerical chromosorne aberrations in primary human liver tumours: Relevance to tumour characteristics and prognosis
27. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: Its clinical and prognostic significance
28. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
29. Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens
30. Molecular basis of multistep hepatocarcinogenesis: Genetic and epigenetic events
31. Molecular epidemiology and carcinogenesis: Endogenous and exogenous carcinogens
32. Cell proliferation and cell loss in nodule-in-nodule hepatocellular carcinoma
33. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma
34. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
35. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion
36. Balance of cell proliferation and apoptosis in breast carcinogenesis
37. Molecular epidemiology of human cancer
38. Genetic aspects of hepatocellular carcinogenesis
39. Beta-catenin signaling and cancer
40. Molecular mechanism of hepatocarcinogenesis
41. Prognostic significance of pathological and biological factors in hepatocellular carcinoma
42. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
43. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma
44. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry
45. Role of angiogenesis in hepatitis and hepatocellular carcinoma
46. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
47. Intratumor microvessel density as a prognostic factor in cancer